Data as of Mar 07
| -4.02 / -2.97%|
The 15 analysts offering 12-month price forecasts for Pharmacyclics Inc have a median target of 165.00, with a high estimate of 225.00 and a low estimate of 121.00. The median estimate represents a +25.44% increase from the last price of 131.54.
The current consensus among 17 polled investment analysts is to Buy stock in Pharmacyclics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.